Lennar Corporation, together with its subsidiaries, operates as a homebuilder primarily under the Lennar brand in the United States. It operates through Homebuilding East, Homebuilding Central, Homebuilding Texas, Homebuilding West, Financial Services, Multifamily, and Lennar Other segments. The company's homebuilding operations include the construction and sale of single-family attached and detached homes, as well as the purchase, development, and sale of residential land; and development, construction, and management of multifamily rental properties. It also offers residential mortgage financing, title, insurance, and closing services for home buyers and others, as well as originates and sells securitization commercial mortgage loans. In addition, the company is involved in the fund investment activity. It primarily serves first-time, move-up, active adult, and luxury homebuyers. The company was founded in 1954 and is based in Miami, Florida.

Lennar Corporation Class A

Morgan Stanley analyst Alain Gabriel maintained a Buy rating on Glencore today and set a price target of p610.00. According to TipRanks, Gabriel is...

Glencore (GLEN) Receives a Buy from Morgan Stanley

The average 30-year fixed-rate mortgage (FRM) increased by 8 basis points to 6.38% this week, rising for a fifth consecutive week and hitting the h...

U.S. Mortgage Rates Ramp to 7-Month High as Spring Home-Buying Season Kicks Off

In a report released on March 31, Christian Faitz from Kepler Capital maintained a Hold rating on Lenzing, with a price target of €25.00. The compa...

Kepler Capital  Sticks to Their Hold Rating for Lenzing (0NCV)

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Burlington Stores (BURL), Lennar (LEN) and ...

Analysts Offer Insights on Consumer Cyclical Companies: Burlington Stores (BURL), Lennar (LEN) and Hermes International (OtherHESAF)

Lenz Therapeutics, Inc. (($LENZ)) has held its Q4 earnings call. Read on for the main highlights of the call. Lenz Therapeutics struck a cautiously...

Lenz Therapeutics Earnings Call: High Spend, Growing Traction

The average 30-year fixed-rate mortgage (FRM) increased by 16 basis points to 6.38% this week, rising for a fourth consecutive week and hitting the...

U.S. Mortgage Rates Leap to 6-Month High as U.S.-Iran War Fuels Inflation Fears

Ellenbarrie Industrial Gases Limited ( ($IN:ELLEN) ) has issued an announcement. Ellenbarrie Industrial Gases Limited has announced the closure of ...

Ellenbarrie Industrial Gases Closes Trading Window Ahead of FY26 Results

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sanofi (SNYNF) and LENZ Therapeutics (LENZ). Sanofi (SNYNF) In a ...

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and LENZ Therapeutics (LENZ)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on LENZ Therapeutics (LENZ) and CVS Health (CVS) with b...

Analysts’ Top Healthcare Picks: LENZ Therapeutics (LENZ), CVS Health (CVS)

Glencore ( ($GB:GLEN) ) just unveiled an update. Glencore has disclosed that Chief Executive Officer Gary Nagle has received the vesting of previou...

Glencore CEO Gary Nagle Receives Vesting of Long-Term Share Awards

In a report released on March 19, Christian Faitz from Kepler Capital maintained a Hold rating on Lenzing, with a price target of €34.00. The compa...

Kepler Capital  Reaffirms Their Hold Rating on Lenzing (0NCV)

Analysts fell to the sidelines weighing in on Torrid Holdings (CURV – Research Report) and Lennar (LEN – Research Report) with neutral ratings, ind...

Analysts Offer Insights on Consumer Cyclical Companies: Torrid Holdings (CURV) and Lennar (LEN)

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on CAVA Group, Inc. (CAVA – Research Report) a...

Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: CAVA Group, Inc. (CAVA) and Lennar (LEN)

In a report released today, Jonathan Bettenhausen from Truist Financial maintained a Hold rating on Lennar, with a price target of $95.00. In addit...

Truist Financial Keeps Their Hold Rating on Lennar (LEN)

Lennar Corporation (($LEN)) has held its Q1 earnings call. Read on for the main highlights of the call. Lennar’s latest earnings call struck a caut...

Lennar Earnings Call Highlights Discipline Amid Margin Squeeze

Evercore ISI analyst Stephen Kim maintained a Sell rating on Lennar today and set a price target of $92.00. Kim covers the Consumer Cyclical sector...

Lennar (LEN) Gets a Sell from Evercore ISI

The stock of homebuilder Lennar ($LEN) is sinking after the company delivered quarterly financial results that fell short of Wall Street’s forecast...

LEN Earnings: Lennar Stock Falls as Financial Results Miss Wall Street’s Expectations

BTIG analyst Ryan Gilbert maintained a Sell rating on Lennar on March 10 and set a price target of $90.00. According to TipRanks, Gilbert is ranked...

Current Quarter	$1.24	Next Quarter	$1.72
Current Year	$6.05	Next Year	$7.84
QoQ Growth	+38.7%	YoY Growth	+29.6%
3Y EPS CAGR	+0.1%	Target Price	$99.64
Consensus	Buy	Upside	+12.0%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LEN	$88.93	+0.34%	3.42M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LEN	$88.93	+0.3%	3.42M
3
4
5
6

LEN

LEN

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Lennar Corporation Class A Data in Excel

Get Lennar Corporation Class A Data in Excel